Cordis EX700 EXOSEAL Vascular Closure Device 7F

Request Price & Availability Request Price on WhatsApp

World Wide Delivery!

Cathlab Products, Coronary Stents, Coronary Ballons, Coronary Guidewire, Neuro Intervention, Interventional Cardiology supplier peripheral intervention supplier, Laboratory, Endoscopy.

Boston Scientific, Terumo, Abbott, Medtronic, Cordis, EV3 , Terumo Neuro , Microvention Bard, Smith and Nephew, BD, Roche, Siemens, Asahi, Stryker, Merit Medical, Beckman Coulter, Biorad, Cook Medical, products Contact us for product availability, REF code confirmation, quantity-based pricing, and export details.

Mobile: +1 940 618 9768
Whatsapp, Wechat, VIber, Signal, Botim, Telegram - Available

Cordis EXOSEAL® Vascular Closure Device EX700
The Cordis EXOSEAL® Vascular Closure Device EX700 is a 7F vascular closure device designed for safe, simple, and secure closure of femoral artery access sites after diagnostic and interventional catheterization procedures. Cordis identifies the EXOSEAL platform as being indicated for femoral artery puncture site closure in procedures using standard 5F, 6F, or 7F vascular sheath introducers, with EX700 representing the 7F configuration.

Engineered for efficient post-procedure management, the EXOSEAL device is designed to help reduce time to hemostasis and ambulation while supporting a streamlined femoral closure workflow. Cordis product materials describe the EXOSEAL system as combining clinical safety and ease of use, with a closure concept intended to improve physician confidence and patient outcomes.

A key advantage of the Cordis EX700 is its precise extravascular closure design. Cordis highlights the EXOSEAL platform as using trusted bioabsorbable technology, while product materials emphasize that the system leaves nothing behind in the artery, with no suturing, no cinching, and no metal implant. This artery-sparing approach is intended to support reliable closure without leaving a permanent intravascular component.

The EX700 is designed for use with a 7F sheath introducer up to 12 cm working length. Cordis brochures list the 7F model as EX700CE in international materials, confirming its role as the 7F EXOSEAL option within the product family. Product literature also highlights easy-to-use functionality and a closure process designed for practical use in cath lab and vascular intervention settings.

Built for modern vascular access management, the Cordis EXOSEAL EX700 helps clinicians achieve dependable femoral artery closure after catheter-based procedures while supporting patient comfort and procedural efficiency. Its bioabsorbable extravascular plug technology and dedicated 7F compatibility make it a dependable option for femoral access site management in diagnostic and interventional practice.

Key Features
7F Vascular Closure Device: EX700 is the 7F EXOSEAL configuration for femoral access site closure.
Femoral Artery Closure: Indicated for closure of femoral artery puncture sites after catheterization procedures.
Precise Extravascular Closure: Designed to provide closure outside the artery using a bioabsorbable plug system.
Bioabsorbable Technology: Uses a polyglycolic acid (PGA) plug as part of the closure system.
Nothing Left Behind in the Artery: No suturing, no cinching, and no metal implant.
Compatible with Sheaths up to 12 cm: Intended for use with 7F sheath introducers up to 12 cm working length.
Supports Faster Recovery Milestones: Designed to reduce time to hemostasis and ambulation.

Clinical Applications
Femoral artery puncture site closure after diagnostic catheterization.
Femoral artery closure after interventional catheterization procedures.
Cath lab and vascular intervention access-site management.

Product Information
Brand: Cordis.
Product: EXOSEAL® Vascular Closure Device.
Reference Number: EX700.
Category: Vascular Closure Device.
Size: 7F.
Technology: Bioabsorbable extravascular plug closure.
Application: Femoral artery access site closure following diagnostic or interventional procedures.